HSCSW

HeartSciences Inc.

HeartSciences Inc. (HSCSW) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 47.8, with 0/3 trend checks passing.

Price

$0.06

-0.01 (-16.64%)

Day range

$0.06–$0.06

52wk $0.05–$0.07

Volume

Avg —

Trend score

0/3

Downtrend

RSI (14)

47.8

Neutral

✕Price above MA50✕Price above MA200✕MA50 above MA200

Change stock

Search another ticker to view its stock analysis page.

Chart View

HSCSW with MA50 and MA200

Dashboard News TradingView

HSCSW • 2025-06-12 → 2026-07-16

PriceMA50MA200

Technical Indicators

Key levels & signals

MA50

$0.07-8.19% vs price

MA200

$0.08-23.14% vs price

RSI (14)

47.8Neutral zone

MACD Signal

MixedMACD near signal line

Macro Support

$0.06–$0.060.8% below price · 5 touches

Support Quality

5 touches1.3× zone volume

Valuation

HSCSW valuation multiples (TTM)

P/E Ratio

—

P/S Ratio

—

P/B Ratio

—

EV/EBITDA

—

Valuation multiples are provided by Financial Modeling Prep when available.

Analyst Ratings

HSCSW analyst consensus

Avg Price Target

—

High Target

—

Low Target

—

Analyst Coverage

—

Analyst ratings and price targets are provided by Financial Modeling Prep when available.

Chart Summary

Trend summary for HSCSW

HeartSciences Inc. (HSCSW) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $0.06, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 8.2% and below the 200-day moving average by 23.1%.

Momentum and stretch context

HSCSW currently has an RSI reading of 47.8, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.

What traders may watch next

For traders reviewing HSCSW next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.

Company profile

About HeartSciences Inc.

Heart Test Laboratories, Inc. is a medical technology enterprise dedicated to the creation of diagnostic instruments for cardiovascular health. The company's primary offering is the MyoVista wavECG, a sophisticated 12-lead resting electrocardiograph. This device provides essential diagnostic insights into cardiac dysfunction, in addition to supplying standard 12-lead resting ECG information. Serving a diverse range of medical environments, its products are adopted by clinics, physicians' offices, urgent care centers, and hospitals. Founded in 2007, the firm's operations are headquartered in Southlake, Texas.

Share dilution

HSCSW shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.